Xoxe CV 500mg Tablet by CORONA REMEDIES — wholesale price and bulk supply

About Xoxe CV 500mg Tablet

Xoxe CV 500mg Tablet is a tablet pharmaceutical product marketed by CORONA REMEDIES containing Cefixime 200mg + Clavulanic Acid 125mg, available for wholesale and bulk purchase on PharmaBag.

Xoxe CV 500mg Tablet specifications

Product specifications
Product NameXoxe CV 500mg Tablet
Salt CompositionCefixime 200mg + Clavulanic Acid 125mg
Manufacturer / MarketerCORONA REMEDIES
Dosage FormTablet
Product CategoryGeneric

Prices are wholesale rates offered by verified suppliers and exclude GST unless stated. Product information is provided for trade reference only and is not medical advice. Always verify the pack, batch and prescribing information before dispensing.

Frequently asked questions about Xoxe CV 500mg Tablet

What is the salt composition of Xoxe CV 500mg Tablet?

Xoxe CV 500mg Tablet contains Cefixime 200mg + Clavulanic Acid 125mg. Always confirm the composition and strength against the product pack and the prescribing information before dispensing.

Who manufactures Xoxe CV 500mg Tablet?

Xoxe CV 500mg Tablet is marketed by CORONA REMEDIES. PharmaBag sources it through verified wholesale suppliers who hold valid drug licences.

Can I buy Xoxe CV 500mg Tablet in bulk for my pharmacy or hospital?

Yes. PharmaBag is a B2B wholesale platform serving retail pharmacies, hospitals, clinics and distributors across India. Buyers complete a one-time verification with a drug licence and GST or PAN details, after which Xoxe CV 500mg Tablet can be ordered in bulk with a GST invoice and pan-India delivery.

Is a GST invoice provided for Xoxe CV 500mg Tablet?

Yes. Every order placed on PharmaBag, including Xoxe CV 500mg Tablet, is billed with a GST invoice from the supplying wholesaler at the applicable GST rate.

Alternatives to Xoxe CV 500mg Tablet

Other wholesale medicines with a comparable salt composition (Cefixime 200mg).

More from CORONA REMEDIES

View all CORONA REMEDIES products →

Browse by generic molecule